The latest closing stock price for Travere Therapeutics as of November 20, 2024 is 17.86.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $10,907 today, roughly 11 times their original investment - a 22.93% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 20.33, which is 13.8% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 71.3% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 9.79.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $10,907 today, roughly 11 times their original investment - a 22.93% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 20.33, which is 13.8% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 71.3% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 9.79.